JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA?-Reference-Cited by-同舟云学术

JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA?

Published:1983-03 Issue:8324 Volume:321 Page:587
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wiltshaw Eve,Evans BarrieD,Jones AdrianC,Baker JoanW,Calvert A.Hilary

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Riboflavin deficiency and congenital malformations;Warkany,1975

2. Cis-dichlorodiammineplatinum (II) in the treatment of gynaecological malignancies: Phase II trials of the gynaecologic oncology group;Thigpen;Cancer Treat Rep,1979

3. Toxic effects of cis-dichlorodiammineplatinum II in man;Von Hoff;Cancer Treat Rep,1979

4. Early clinical studies with cis-diammine-L, 1-cyclobutane dicarboxylate platinum II;Calvert;Cancer Chemoth Pharmacol,1982

5. Primary bioassay of human tumor stem cells;Hamburger;Science,1977

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy;Journal of Hematology & Oncology;2022-04-27

2. The clinical development of carboplatin – A personal perspective;Inorganica Chimica Acta;2019-12

3. The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor activity;The International Journal of Biochemistry & Cell Biology;2002-01

4. Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a hellenic co-operative oncology group study;European Journal of Cancer;1996-03

5. Very high-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer;European Journal of Cancer;1995-11